Arbutus Biopharma Corporation Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 11/14/2024 | 21.71 M | $83.58 M | 3.57% | 11.49% |
| WHITEFORT CAPITAL MANAGEMENT, LP | 11/14/2024 | 12.87 M | $49.54 M | 0.00% | 6.81% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 12.22 M | $47.04 M | 100.00% | 6.47% |
| VANGUARD GROUP INC | 11/13/2024 | 8.92 M | $34.34 M | 27.01% | 4.72% |
| TWO SEAS CAPITAL LP | 11/14/2024 | 8.39 M | $32.29 M | -2.15% | 4.44% |
| STATE STREET CORP | 11/14/2024 | 4.41 M | $16.97 M | 50.18% | 2.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.45 M | $13.28 M | 4.09% | 1.82% |
| FOURWORLD CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.97 M | $11.44 M | 0.00% | 1.57% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.90 M | $11.17 M | -3.30% | 1.53% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 2.09 M | $8.04 M | -36.48% | 1.11% |
| BLACKBARN CAPITAL PARTNERS LP | 11/14/2024 | 2.07 M | $7.97 B | 0.00% | 1.10% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 1.68 M | $6.47 M | 0.00% | 0.89% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1.37 M | $5.28 M | 0.18% | 0.73% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 1.27 M | $4.89 M | -12.11% | 0.67% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.21 M | $4.67 M | 218.52% | 0.64% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 1.03 M | $3.97 M | -38.87% | 0.55% |
| CORBIN CAPITAL PARTNERS, L.P. | 11/12/2024 | 853,304 | $3.29 M | 0.00% | 0.45% |
| SABA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 676,427 | $2.60 M | 3.84% | 0.36% |
| WOODLINE PARTNERS LP | 11/14/2024 | 668,153 | $2.57 M | -27.89% | 0.35% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 612,277 | $2.36 M | 0.00% | 0.32% |
| CITADEL ADVISORS LLC | 11/14/2024 | 607,744 | $2.34 M | 319.50% | 0.32% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 560,407 | $2.16 M | 256.20% | 0.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 496,818 | $1.91 M | 4.59% | 0.26% |
| FREESTONE CAPITAL HOLDINGS, LLC | 11/14/2024 | 443,200 | $1.71 M | -18.87% | 0.23% |
| BANK OF MONTREAL /CAN/ | 11/13/2024 | 440,313 | $1.69 M | 24.10% | 0.23% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 419,905 | $1.62 M | -8.23% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 371,800 | $1.43 M | 217.78% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 352,571 | $1.36 M | -28.59% | 0.19% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 313,307 | $1.21 M | 0.00% | 0.17% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 278,400 | $1.07 M | 100.00% | 0.15% |
| SWISS NATIONAL BANK | 11/07/2024 | 276,300 | $1.06 M | 100.00% | 0.15% |
| BARCLAYS PLC | 11/19/2024 | 272,029 | $1.05 M | 466.33% | 0.14% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 250,960 | $966,196 | 20.09% | 0.13% |
| QUINN OPPORTUNITY PARTNERS LLC | 11/13/2024 | 235,132 | $905,258 | 42.39% | 0.12% |
| LMR PARTNERS LLP | 11/07/2024 | 197,025 | $758,546 | -22.86% | 0.10% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 189,398 | $729,183 | 127.43% | 0.10% |
| RHUMBLINE ADVISERS | 11/12/2024 | 177,874 | $684,805 | -3.89% | 0.09% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 170,287 | $655,605 | 100.00% | 0.09% |
| UBS GROUP AG | 11/14/2024 | 168,374 | $648,240 | 202.48% | 0.09% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 145,797 | $561,319 | 856.17% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 139,000 | $535,150 | 125.28% | 0.07% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 137,620 | $529,837 | 0.00% | 0.07% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2024 | 134,270 | $516,940 | 1,228.49% | 0.07% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 115,021 | $442,831 | 100.00% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 104,939 | $404,015 | -81.49% | 0.06% |
| STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 98,557 | $379,444 | 100.00% | 0.05% |
| JPMORGAN CHASE & CO | 12/26/2024 | 89,586 | $344,906 | 10.97% | 0.05% |
| FMR LLC | 11/13/2024 | 83,280 | $320,628 | -17.40% | 0.04% |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 11/08/2024 | 81,947 | $315,496 | -8.64% | 0.04% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 81,711 | $314,587 | 0.00% | 0.04% |
Arbutus Biopharma Corporationinstitutional Ownership - FAQ's
During the previous two years, 173 institutional investors and hedge funds held shares of Arbutus Biopharma Corporation. The most heavily invested institutionals were:
MORGAN STANLEY: 21.71 M
Whitefort Capital Management, LP: 12.87 M
BlackRock Funding, Inc. /DE: 12.22 M
VANGUARD GROUP INC: 8.92 M
Two Seas Capital LP: 8.39 M
STATE STREET CORP: 4.41 M
53.32% of Arbutus Biopharma Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 113.15 M shares in the last 24 months. This purchase volume represents approximately $370.01 M in transactions.